Body mass index in young men and risk of inflammatory bowel disease through adult life: a population-based danish cohort study

ABSTRACT Body mass index (BMI) is associated with increased future risk of inflammatory bowel disease(IBD) particularly Crohn’s disease(CD), where associations with high and low BMI have

been observed. Most studies are based on adult women. We aimed to explore the impact of BMI in men entering adult life on their long-term risk of developing IBD. A total of 377,957 men born

during 1939–1959, with BMI measured at draft boards at mean age 19, were followed from 1977, or time of examination, to end of 2015. Risk of IBD was assessed using Cox regression. During 13

million person-years of follow-up, 1,523 developed CD and 3,323 UC. Using normal weight as reference, for CD the following HRs were observed: BMI < 18.5, 1.35; 95% CI, 1.12–1.62, BMI

25–29.9; 0.83; 95% CI, 0.68–1.02. and BMI > 30 1.20; 95% CI, 0.75–1.90). The increased risk of CD in underweight was maintained up until age 60 not explained by known effects of smoking.

For UC, minor inverse associations were observed. Restricted cubic splines revealed a U-shape association between BMI and CD, but not UC. Low BMI of men entering adult life is associated

with an increased incidence of CD and UC up to 40 years later. SIMILAR CONTENT BEING VIEWED BY OTHERS BODY MASS INDEX AND RISK OF CANCER IN YOUNG WOMEN Article Open access 15 March 2024

BURDEN OF DISEASES ATTRIBUTABLE TO EXCESS BODY WEIGHT IN THE MIDDLE EAST AND NORTH AFRICA REGION, 1990–2019 Article Open access 20 November 2023 ADULTS WITH CROHN’S DISEASE EXHIBIT ELEVATED

GYNOID FAT AND REDUCED ANDROID FAT IRRESPECTIVE OF DISEASE RELAPSE OR REMISSION Article Open access 28 September 2021 INTRODUCTION Inflammatory bowel diseases are somehow diseases of

modernity, although there is uncertainty as to what aspects of modernity are responsible. An increased prevalence of obesity occurred particularly in the late 20th century1, which is widely

appreciated to induce a pro-inflammatory state associated with both systemic2 and local gut inflammation3. It is widely appreciated that at the time of diagnosis particularly in younger

subjects with Crohn’s disease that body mass index is reduced4,5,6. However in a limited number of studies, elevated body mass index associates with future risk of Crohn’s disease(CD) but

not ulcerative colitis(UC)7,8,9, although to date studies have largely been in adult women and children8. In one prospective study in adult women10 and a case-control study in both sexes9,

low BMI, was also associated with risk. However in a prospective study in adult women from the USA the Nurses Health Study(NHS)7, there was no association, although this could relate to the

way low BMI was defined. Nor was there any association in a large study of children aged 138, although this study did observe a modest association of low BMI with risk of UC. Low BMI rather

than being a risk factor could be a reflection of reverse causation, there being increasing awareness that there may be a long prodrome to Crohn’s disease (CD). Seroconversion to yeast

antigens and elevated inflammatory markers are found up to 15 years before diagnosis11,12,13. There is no corresponding similar evidence for ulcerative colitis (UC). The lack of association

of low BMI with risk of CD in a large study of children8 raises the possibilities that either changes in physiology and immune function, sub-clinical disease onset, or changes in risk factor

profile, notably initiation of smoking, occurring at the time of puberty, could possibly explain the association with adult risk. We had the unique opportunity to study a large nationally

representative cohort of Danish young men, to assess the association of BMI with future risk of CD, for the first time prospectively in men. The possible effect of smoking was modelled in a

sensitivity analysis. RESULTS Among the 377,957 men available for inclusion in the study, the mean (SD) age at conscription board examination was 19.9 (1.7) years and the mean (SD) BMI was

21.8 (2.5) kg/m2. At this time, 6% were underweight, 85% were normal weight, 8% were overweight, and only 1% were obese. The descriptive statistics of the study population are presented in

Table 1. RISK OF CROHN’S DISEASE AND ULCERATIVE COLITIS During around 13 million person-years of follow up, 1,523 men were diagnosed with CD at a mean (SD) age of 47.0 (13.0) years, and

3,323 men were diagnosed with UC at a mean (SD) age of 49.7 (12.0) years. The median (IQR) time from conscription board examination to diagnosis of CD was 27.7 (6.1; 47.4) years and the

median (IQR) time from the examination to diagnosis of UC was 31.3 (8.0; 48.3) years. There was no statistically significant difference in time to diagnosis of CD (P = 0.2) or UC (P = 0.9),

between underweight, normal weight, overweight, and obese cases. BMI CATEGORIES We further investigated the association between BMI and, respectively, CD and UC, by using BMI as a

categorical variable of underweight, normal weight, overweight, and obesity (Table 2). In CD, using normal weight men as the reference group, we observed a significantly increased risk for

CD in underweight men (HR, 1.35; 95%CI, 1.12–1.62), and no statistically significant associations with overweight (HR, 0.83; 95%CI, 0.68–1.02) or obesity (HR, 1.20; 95%CI, 0.75–1.90) (Table 

2). In UC, when using BMI as a categorical variable, we observed a pattern similar to the one found when using BMI as a continuous variable, i.e. a tendency towards an inverse association

with UC, although only reaching statistical significance in the overweight category (HR, 0.86; 95% CI, 0.75–0.98) (Table 2). In an additional analysis, performed to facilitate comparison

with the NHS, where BMI categories were defined differently, we subdivided the normal weight conscripts. Compared with the group with BMI 20–22.5 kg/m2, the risk of CD was highest in those

with lowest BMI within the normal range (18.5–20 kg/m2; HR, 1.25; 95% CI, 1.09–1.44), while being unaltered in those with highest BMI within the normal range (22.5–25 kg/m2; HR, 1.05; 95%

CI, 0.92–1.20). BMI AS A CONTINUOUS MEASURE First, we investigated the association between BMI and risk of CD and UC, using BMI at the conscription board examination as a continuous

variable. The association between BMI and CD tended to be U-shaped with significant departure from linearity (P = 0.0002, whereas the association between BMI and UC did not demonstrate

non-linearity (P = 0.9). Next, we estimated risk of CD based on a spline model, using mean BMI (21.8 kg/m2) as the reference level. We observed a statistically significant inverse

association between BMI under the reference level and risk of CD, indicated by HRs and confidence intervals for CD above 1.0 in low weight men (Fig. 1). For BMIs above the reference level,

we did not observe a significant association with risk of CD. We further examined the association between BMI and CD according to age at diagnosis of CD. For all ages of CD diagnosis, we

found a similar non-linear (U-shaped) pattern between conscript BMI and risk of CD. Notably, this non-linear association between BMI in young adulthood and later risk of CD existed up to age

60 years at CD diagnosis (Fig. 2). A BMI of 18.0 kg/m2 at age 19 years associated with an up to 2-fold increased risk of CD in men diagnosed in their 40ies and 50ies. For UC, we observed a

statistically significant inverse linear association with BMI (Fig. 3). For each 1 kg/m2 increase in BMI, the HR of UC decreased by 2% (HR, 0.98; 95% CI, 0.97–1.00). However, effect-sizes

stayed quite modest with less than 10% increase in risk of UC for a BMI of 18 kg/m2 and 15% decrease in risk of UC for a BMI of 30 kg/m2 (Fig. 4). SENSITIVITY ANALYSES * (i) The effect of

smoking Assuming (1) no true BMI-effect on CD, (2) that the prevalence of smoking was 70% (the prevalence in Denmark in 196014 in the study population), and (3) that the association between

smoking and CD corresponded to HR = 2.0 (estimates ranging from 1.3–1.7 in the literature15), smoking had to be associated with a 4.8 kg/m2 decrease in BMI to fully explain the observed

result of increased risk of CD in underweight men. When changing the prevalence of smoking to 50% (1980s Denmark14), smoking would have to be associated with a decrease in BMI of 3.9 kg/m2

to fully explain the observed results. * (ii) Other sensitivity analyses We excluded potential prevalent IBD cases by postponing start of follow up from 1/1/1977 to 1/1/1980. The patterns of

association were virtually unchanged (Supplementary Figs 2 and 3). In a further sensitivity analysis, restricting the cohort to those men recruited between 1/1/1977 (the beginning of the

NPR) and 31/12/1984 (the end of Draft Board examination), a similar non-linear association was observed between BMI and CD risk (Supplementary Fig. 4). The association between BMI and UC was

also consistent with main findings in sensitivity analyses (Supplementary Fig. 5). DISCUSSION In this population-based cohort study of 377,957 men followed from early adulthood up to age

50+ years, we have demonstrated, that underweight at mean age 19 is associated with an increased long-term risk of CD. The association did not decrease in magnitude with increasing

time-to-diagnosis until the age of 60. The association was non-linear with a tendency, although not significant, for risk to rise with higher BMI, but power was limited in this latter group.

For UC, we observed a statistically significant negative linear association with BMI throughout its range. Smoking to fully explain our findings would have had had to be associated with an

implausibly large effect on BMI. Previous literature on the subject is sparse, especially in men. A single smaller prospective study suggested no association between BMI and risk of IBD in

men and women16, whereas two studies in women reported an association between elevated BMI and increased risk of CD, but not UC7. The DNBC study, which was based on younger Danish women,

additionally provided evidence that low as well as high BMI was a risk factor for a diagnosis of CD before the age of 4010 as did an earlier case-control study. In the present study, with

longer follow-up after BMI measurement, low BMI was found to be a risk factor for the development of CD up to the age of 60. This may also relate to sex-differences in the association

between BMI and disease risk. Categorization of BMI may influence results. In the NHS population from the US with a higher prevalence of overweight, and a lower prevalence of smoking, low

BMI at baseline was not statistically significantly associated with CD risk (HR, 1.14; 95% CI, 0.81–1.60), but the lowest BMI category was defined by BMI < 20 kg/m2, rather than by the

WHO measure of underweight of BMI < 18.517 used in the present study. In our additional analysis we found that low normal BMI (BMI18.5- < 20 kg/m2) was associated with an almost

identical HR to that seen in the Nurses’ Health Study for BMI < 20. In the only study in children, aged 7–13 years, from the Copenhagen School Health Records Register (CSHRR), BMI was

positively associated with CD diagnosed before the age of 30, but not thereafter. Notably, low BMI did not associate with CD for either sex among school children, nor was there any evidence

of a non-linear association, despite the fact that children were drawn from the same population as the conscripts of the present study18. There was however a modest association of low BMI

with risk of UC. There are a number of potential explanations as to why low BMI should emerge as a risk factor for CD only after puberty. It could be due to a change in risk factor profile

during adolescence, the most important of these being smoking, which may associate with both decreased BMI and increased risk of CD. However, for UC, in whom smoking is protective, the risk

decreased with increasing BMI, which is counter to what would be expected if smoking behavior was an influence on low BMI in this cohort. Other current evidence speaks against a strong

association between smoking and BMI in young adulthood19. The Surgeon General’s report20 indicated that for smokers aged 18 or younger, BMI was the same or higher in smokers, with reductions

in BMI only emerging after the age of 35. Furthermore, the association between low BMI and CD observed among young women in the DNBC study was only modestly attenuated after controlling for

smoking10, and there was no effect of controlling for smoking on the effect of BMI in the NHS6. Finally, in a recent study from the UK General Practice Research Database exploring whether

smoking explained the U-shaped association between BMI and mortality, exclusion of ever smokers did not attenuate the asssociations observed which included non-liver GI diseases as an

undifferentiated group21. Combined with our simulations presented under the sensitivity analyses, we find it unlikely that the observed association is explained by smoking alone, although

smokers who are pre-disposed to excessive weight loss may be at increased risk. Another explanation is reverse causality, i.e. that low BMI in young adulthood reflects early sub-clinical

disease manifesting around the time of completion of puberty. Elevated ASCA are present many years prior to diagnosis of CD12 and elevations in serum C-reactive protein and IL-6 are present

up to 15 years prior to diagnosis11. Further evidence of a prolonged pre-clinical phase comes from family studies in CD demonstrating increased intestinal permeability and fecal calprotectin

in first degree relatives who are at themselves at increased risk of developing disease22. Still, the magnitude of the reduction of BMI would be difficult to attribute to an entirely

sub-clinical disease manifesting up to 40 years later. Low BMI in early adulthood itself could be a risk factor for CD. Starvation23 as well as obesity24 impair gut barrier function and

increase gut permeability which are implicated in the pathogenesis of CD25. IGF-1 levels, which are reduced in starvation or low protein intake26 and obesity27,28,29, IBD, differences in

BMI, progress of puberty30 and sex hormone production31. In women from the NHS population, levels of free testosterone were strongly related to reduced future risk of CD but not UC32, with

effect sizes of around a 4 fold reduction in risk in the 4th and 5th quintiles of serum levels compared to the lowest. Still, these hypotheses merit further investigation. The U-shaped

association between BMI and future risk of CD could be a reflection not only of U-shaped associations of risk factors for CD with BMI, but could reflect two different types of

aetio-pathological pathways. There are no prospective studies on the influence of BMI on disease phenotype, although there is a suggestion that pure ileal disease, young age at diagnosis and

no prior history of appendectomy associate with greater weight loss prior to and reduced BMI at the time of diagnosis33. There was no suggestion of similar U-shaped association of BMI with

risk for UC. Of the previous studies7,9,10,16, only the study in Danish children reported an association between BMI and risk of UC8. The statistically significant inverse association

observed in the present study was relatively modest in magnitude, and former studies may have been inadequately powered to observe the association. The primary strength of the present study

is the considerable size, the geographically broad population-based cohort, and the long-term follow-up with minimal loss. A further strength is the validated method for ascertainment of

cases with case-status being defined using discharge diagnosis from the NPR that covers all Danish hospitals. The risk of selection bias is therefore minimal and IBD diagnoses in the NPR

have been found to be valid and almost complete34. Still, there are potential limitations other than the lack of ability to control for confounders discussed above that need consideration.

The men had to be healthy enough to attend the conscription board examination33. Approximately 5–10% of each birth cohort was exempted from the conscription board examination, some of which

were due to enrollment in military services before the examination and other because of various health conditions35, which, however, are unlikely to bias the estimates of the present study.

The absence of any BMI data later in adulthood is another weakness, but BMI at entrance to adult life is known to track BMI in later adult life36 and is associated with other hard clinical

endpoints such as cardiovascular and cancer death many decades into the future37,38. It would have been ideal to have direct measures of fat and lean body mass and visceral adiposity which

associate more strongly with the immunological phenomena associated with obesity39. However, these were not available, and would most likely serve to strengthen the observed association.

Some of the men were included before establishment of the NPR in 1977, which may explain the relatively high median age at IBD diagnosis in this study due to initial inclusion of prevalent

cases, who had been diagnosed years before. Sensitivity analyses excluding prevalent cases (with first recorded diagnosis <1980) did not alter our findings. Restricting the analysis to

men who had their baseline evaluation after 1976, when the NPR was established, again did not alter the findings, thereby supporting that the association between low BMI and risk of CD up

until the age of 60 is not explained by misclassification of age at diagnosis. This also provides reassurance that milder cases diagnosed before 1977, who subsequently did require

hospitalization, do not introduce bias. Finally, few cases were obese, leaving limited power to study this aspect. In conclusion, our population-based cohort study of 377,957 men followed

from age 19 showed a U shaped association between BMI and risk of CD with a significant association between underweight in young adulthood and later risk of CD, which persisted long-term. A

more modest linear long-term association with reduced BMI was observed with UC. We are unable confidently to attribute all of the associations to confounding from conventional risk factors

in particular smoking, although it is likely that it played some part. Differences in host physiology and immune function occurring at the end of maturation, likely related to hormonal

milieu, may explain our findings, although we cannot preclude an early pre-clinical phase of CD, although this is less likely for UC. METHODS STUDY POPULATION The study population was drawn

from the DCD, which is a nationwide population-based cohort of ethnically homogenous men examined by the conscription board from 1957 through 198440. When turning 18 years, all men in

Denmark were required to attend the conscription board examination, which included a health status, measurement of height and weight, information on educational level, and cognitive ability

assessed by an intelligence test. The total DCD population consisted of 728,160 men. Figure 4 shows the development of the final cohort for analysis of 377,957 men. We excluded 30,226 men

with missing or outlier information on birth year or age at conscription board examination and 10,825 men who emigrated, deceased, or were lost to follow up prior to the examination or

1/1/1977, when the NPR was established. Fifty-one men were diagnosed with IBD before they attended the examination, 284,009 men had a missing measure weight because weight was not recorded

in some regions, with a smaller number (25,901) having missing height. BMI was calculated as weight divided by height-squared (kg/m2). Data was checked for outliers and one extreme outlier

(BMI of 85 kg/m2) was removed. We defined categories of body size according to the WHO definition of underweight (BMI < 18.5), normal weight (18.5 ≤ BMI < 25), overweight (25 ≤ BMI 

< 30), and obesity (BMI ≥ 30)7. DATA LINKAGE In April 1968, the Danish Civil Registration System assigned a unique personal identification number to all Danish citizens alive and residing

in Denmark and has assigned such a number to all born in Denmark after that date. Using the personal identification number, we obtained vital statistics of all the men and through linkage

to the National Patient Register (NPR), we obtained diagnoses of IBD. Starting on 1/1/1977, the NPR holds discharge diagnosis based on the ICD coding system (versions 8 and 10). Based on the

ICD codes for CD (ICD-8: 563.00–563.09. ICD-10: K50) and UC (ICD-8: 563.19 + 569.04. ICD-10: K51) we identified incident cases of IBD. Patients who, over time, shifted from one IBD

diagnosis to another were counted as having the latest recorded diagnosis, but included as cases from the date of the first IBD diagnosis. Only cases diagnosed after conscription board

examination were included. IBD diagnoses based on the NPR are almost complete and of high validity34. STATISTICAL ANALYSES We used the Cox proportional hazards regression model to examine

the association between BMI at conscription and risk of CD and UC, respectively. We modelled BMI as a continuous variable and as a categorical variable of underweight, normal weight,

overweight, and obese. The normal weight group was used as the reference in main analyses. In an additional analysis to facilitate comparison with the NHS, the normal weight group was

subdivided into smaller groups (18.5–20, 20–22.5, and 22.5–25 kg/m2) and the heavier subgroup (BMI 22.5–25 kg/m2) was used as reference. The underlying time scale was age. The men examined

were born during a period of 21 years. To control for the increasing prevalence of overweight and obesity, we stratified the analyses by 5-year birth cohorts to allow the baseline hazard to

differ by birth cohort. No interactions between birth cohort and BMI on the risk of CD and UC were found (P for interaction 0.8 for CD and 0.1 for UC; Supplementary Material 1). Furthermore,

birth year was included in the model as an explanatory variable, together with age at conscription board examination, both as continuous variables. We checked the proportional hazards

assumption by testing if the association between BMI and IBD varied within age-at-risk groups (<30, 30–40, 40–50, 50–60, and >60 years) using likelihood ratio tests. No violations of

the proportional hazards assumptions were detected (all P > 0.5). We checked the association for non-linearity using a restricted cubic spline with 3 knots (25th, 50th and 75th

percentile) and the likelihood ratio test. We also checked linearity using restricted cubic splines with 4 and 5 knots, and found that the model did not explain much additional variation

when using more knots (data not shown). Time-to-diagnoses was described using median (interquartile range; IQR) and compared between groups by Kruskal-Wallis test. In an attempt to estimate

the likelihood of bias from smoking in the observed association between BMI and CD, we performed a series of simulations based on varying assumptions. For simplicity, we assumed a linear

association - on the log-hazard scale - between BMI and CD, which was estimated to be approximately true for the association below BMI 21.8 kg/m2, with respect to an estimated approximate

effect of HR = 1.11 per BMI-unit. We performed additional sensitivity analyses in which we excluded potential prevalent cases in the NPR by postponing start of follow-up from 1/1/1977 to

1/1/1980 and also by restricting the cohort to those men whose baseline examination was performed between 1/1/1977 and 31/12/1984. All statistical analyses were performed using Stata 14

(www.stata.com). ETHICS STATEMENT This study was approved by the Danish Health Ministry. This type of research based on pre-existing routinely collected data does not require ethical

permission in Denmark. REFERENCES * Ananthakrishnan, A. N. _et al_. Environmental triggers in IBD: A review of progress and evidence. _Nat Rev Gastroenterol Hepatol._ 15, 39–49 (2018).

Article  Google Scholar  * Mendall, M. A., Patel, P., Ballam, L., Strachan, D. & Northfield, T. C. C Reactive protein and its relation to cardiovascular risk factors: A population based

cross sectional study. _Br Med J._ 312, 1961–5 (1996). Article  Google Scholar  * Poullis, A., Foster, R., Shetty, A., Fagerhol, M. K. & Mendall, M. A. Bowel Inflammation as Measured by

Fecal Calprotectin: A Link between Lifestyle Factors and Colorectal Cancer Risk. _Cancer Epidemiol Biomarkers Prev._ 13, 279–84 (2004). Article  CAS  Google Scholar  * Katz, L. H., Ghersin,

I., Assa, A., Shamir, R. & Daher, S. Anthropometric measures in adolescents with inflammatory bowel disease: A population-based study. _Inflamm Bowel Dis_.,

https://doi.org/10.1093/ibd/izy336 (2018). * Yadav, D. P. _et al_. Body composition in Crohn’s disease and ulcerative colitis: Correlation with disease severity and duration. _Can J

Gastroenterol Hepatol_, 1215035.doi10.1155 (2017). * Back, I. R. _et al_. Body composition in patients with Crohn’s disease and ulcerative colitis. _Arq Gastroenterol._ 54, 109–114 (2017).

Article  ADS  Google Scholar  * Khalili, H. _et al_. Measures of obesity and risk of Crohn’s disease and ulcerative colitis. _Inflamm Bowel Dis._ 21, 361–8 (2015). Article  Google Scholar  *

Jensen, C. B. _et al_. Childhood body mass index and risk of inflammatory bowel disease in adulthood: a population-based cohort study. _Am J Gastroenterol._ 113, 694–701 (2018). Article 

Google Scholar  * Mendall, M. A., Gunasekera, A. V., John, B. J. & Kumar, D. Is obesity a risk factor for Crohn’s disease? _Dig Dis Sci._ 56, 837–44 (2011). Article  CAS  Google Scholar

  * Mendall, M., Harpsøe, M. C., Kumar, D., Andersson, M. & Jess, T. Relation of body mass index to risk of developing inflammatory bowel disease amongst women in the Danish National

Birth Cohort. _PLoS One._ 13(1), e0190600 (2018). Article  Google Scholar  * Lochhead, P., Khalili, H., Ananthakrishnan, A. N., Richter, J. M. & Chan, A. T. Association Between

Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease. _Clin Gastroenterol Hepatol._ 14, 818–824.e6 (2016). Article  CAS  Google Scholar  * van

Schaik, F. D. M. _et al_. Serological markers predict inflammatory bowel disease years before the diagnosis. _Gut._ 62, 683–688 (2012). Article  Google Scholar  * Choung, R. S. _et al_.

Serologic microbial associated markers can predict Crohn’ s disease behaviour years before disease diagnosis. _Alimentary Pharmacology and Therapeutics._ 43, 1–11 (2016). Article  Google

Scholar  * Graham, H. Smoking prevalence among women in the European Community 1950–1990. _Soc Sci Med._ 43, 243–54 (1996). Article  CAS  Google Scholar  * Mahid, S. S., Minor, K. S., Soto,

R. E., Hornung, C. A. & Galandiuk, S. Smoking and inflammatory bowel disease: A meta-analysis. _Mayo Clin Proc._ 81, 1462–71 (2006). Article  Google Scholar  * Chan, S. S. M. _et al_.

Body Mass Index and the Risk for Crohn’s Disease and Ulcerative Colitis: Data From a European Prospective Cohort Study (The IBD in EPIC Study). _Am J Gastroenterol._ 108, 575–82 (2013).

Article  ADS  Google Scholar  * WHO. Physical Status: the use and interpretation of anthropometry. Report of an expert committee (1995). * Bjerregaard, L. G. _et al_. Change in Overweight

from Childhood to Early Adulthood and Risk of Type 2 Diabetes. _N Engl J Med._ 378, 1302–1312 (2018). Article  Google Scholar  * Piiritola, M. _et al_. Association of current and former

smoking with body mass index: A study of smoking discordant twin pairs from 21 twin cohorts. _PLoS One._ 13, e0200140 (2018). Article  Google Scholar  * U.S. Surgeon General. Preventing

Tobacco Use Among Youth and Young Adults. A report from the Surgeon General. US Dep Heal Hum Serv.; 1395 (2012). * Bhaskaran, K., dos-Santos-Silva, I., Leon, D. A., Douglas, I. J. &

Smeeth, L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. _Lancet Diabetes Endocrinol._ 12, 944–953 (2018).

Article  Google Scholar  * Thjodleifsson, B. _et al_. Subclinical intestinal inflammation: An inherited abnormality in Crohn’s disease relatives? _Gastroenterology._ 124, 1728–37 (2003).

Article  Google Scholar  * Müller, M. J. _et al_. Metabolic adaptation to caloric restriction and subsequent refeeding: The Minnesota Starvation Experiment revisited. _Am J Clin Nutr._ 102,

807–19 (2015). Article  Google Scholar  * Gummesson, A. _et al_. Intestinal permeability is associated with visceral adiposity in healthy women. _Obesity._ 19, 2280–2 (2011). Article  Google

Scholar  * Gibson, P. R. Increased gut permeability in Crohn’s disease: Is TNF the link? _Gut._ 53, 1724–5 (2004). Article  CAS  Google Scholar  * Inagaki, T. _et al_. Inhibition of Growth

Hormone Signaling by the Fasting-Induced Hormone FGF21. _Cell Metab._ 8, 77–83 (2008). Article  CAS  Google Scholar  * Gómez, J. M. _et al_. The IGF-I system component concentrations that

decrease with ageing are lower in obesity in relationship to body mass index and body fat. _Growth Horm IGF Res._ 14, 91–96 (2004). Article  Google Scholar  * Lorenzo-Zuniga, V. _et al_.

Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats. _Gut._ 55, 1306–1312 (2006). Article  CAS  Google Scholar  * Dong, C. X. _et al_. The Intestinal

Epithelial Insulin-Like Growth Factor-1 Receptor Links Glucagon-Like Peptide-2 Action to Gut Barrier Function. _Endocrinology._ 155, 370–9 (2013). Article  Google Scholar  * Al-Asmakh, M.

_et al_. The gut microbiota and developmental programming of the testis in mice. _PLoS One_. 13, 9:e103809, 10.1371 (2014) * Markle, J. G. M. _et al_. Sex differences in the gut microbiome

drive hormone-dependent regulation of autoimmunity. _Science._ 339, 1084–8 (2013). Article  ADS  CAS  Google Scholar  * Khalili, H. _et al_. Endogenous levels of circulating androgens and

risk of Crohn’s disease and ulcerative colitis among women: A nested case-control study from the nurses’ health study cohorts. _Inflamm Bowel Dis._ 21, 1378–85 (2015). Article  Google

Scholar  * Elsherif, Y., Alexakis, C. & Mendall, M. Determinants of weight loss prior to diagnosis in inflammatory bowel disease: A retrospective observational study. _Gastroenterol Res

Pract._ 2014, 762191 (2014). Article  Google Scholar  * Fonager, K., Toft Sørensen, H., Nørby Rasmussen, S., Møller-Petersen, J. & Vyberg, M. Assessment of the diagnoses of Crohn’s

disease and ulcerative colitis in a Danish hospital information system. _Scand J Gastroenterol._ 31, 154–9 (1996). Article  CAS  Google Scholar  * Sørensen, T. I. A. & Sonne-Holm, S.

Mortality in extremely overweight young men. _J Chronic Dis._ 30, 359–67 (1977). Article  Google Scholar  * Aarestrup, J. _et al_. Tracking of body mass index from 7 to 69 years of age. _Int

J Obes._ 40, 1376–83 (2016). Article  CAS  Google Scholar  * Jørgensen, T. S. H. _et al_. The U-shaped association of body mass index with mortality: Influence of the traits height,

intelligence, and education. _Obesity._ 24, 2240–7 (2016). Article  Google Scholar  * Strand, B. H., Kuh, D., Shah, I., Guralnik, J. & Hardy, R. Childhood, adolescent and early adult

body mass index in relation to adult mortality: Results from the British 1946 birth cohort. _J Epidemiol Community Health._ 66, 225–32 (2012). Article  Google Scholar  * Brooks, G. C.,

Blaha, M. J. & Blumenthal, R. S. Relation of C-Reactive Protein to Abdominal Adiposity. _American Journal of Cardiology._ 106, 56–61 (2010). Article  CAS  Google Scholar  * Christensen,

G. T. _et al_. Cohort Profile: The Danish Conscription Database(DCD): A cohort of 728 160 men born from 1939 through 1959. _Int J Epidemiol._ 44, 944–953 (2015). Article  Google Scholar 

Download references ACKNOWLEDGEMENTS South West Thames Gastroenterology Research Fund. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Gastroenterology, Croydon University Hospital, Surrey, UK

Michael A. Mendall * Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Capital Region, Copenhagen, Denmark Camilla B. Jensen, Lars H. Ängquist & Tine

Jess * Department of Public Health, Section of Epidemiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark Thorkild I. A. Sørensen * The Novo Nordisk

Foundation Centre for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark Thorkild I. A. Sørensen *

Department of Clinical Medicine, University of Aalborg, Aalborg, Denmark Tine Jess Authors * Michael A. Mendall View author publications You can also search for this author inPubMed Google

Scholar * Camilla B. Jensen View author publications You can also search for this author inPubMed Google Scholar * Thorkild I. A. Sørensen View author publications You can also search for

this author inPubMed Google Scholar * Lars H. Ängquist View author publications You can also search for this author inPubMed Google Scholar * Tine Jess View author publications You can also

search for this author inPubMed Google Scholar CONTRIBUTIONS M.M. is the guarantor for the submission. M.M. study concept and design, interpretation of the data, drafting of manuscript;

C.B.J. analysis and interpretation of data, drafting of manuscript; L.A. statistical analysis, interpretation of the data, critical revision of manuscript for important intellectual content;

T.S. acquisition of data, critical revision of manuscript for important intellectual content; T.J. involved in conception, statistical analysis and critical revision of manuscript. All

authors have approved the final manuscript. CORRESPONDING AUTHOR Correspondence to Michael A. Mendall. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no competing interests.

ADDITIONAL INFORMATION PUBLISHER’S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION RIGHTS AND PERMISSIONS OPEN ACCESS This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation,

distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and

indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to

the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will

need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Reprints and permissions ABOUT THIS ARTICLE

CITE THIS ARTICLE Mendall, M.A., Jensen, C.B., Sørensen, T.I.A. _et al._ Body mass index in young men and risk of inflammatory bowel disease through adult life: A population-based Danish

cohort study. _Sci Rep_ 9, 6360 (2019). https://doi.org/10.1038/s41598-019-42642-8 Download citation * Received: 28 September 2018 * Accepted: 03 April 2019 * Published: 23 April 2019 * DOI:

https://doi.org/10.1038/s41598-019-42642-8 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not

currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative